Phage display is a widely used discovery platform in which peptide sequences are displayed on the surface of bacteriophage particles and screened against a target of interest through iterative rounds of selection, commonly referred to as biopanning.
How Phage Display Identifies Candidate Peptides
A phage display library contains millions to billions of unique peptide sequences, each linked to the DNA encoding it within an individual phage particle. Repeated rounds of binding to an immobilized target, washing away non-binders, and amplifying the bound phage progressively enriches for sequences with the desired binding property.
From Phage Hit to Synthetic Research Peptide
- Sequencing of enriched phage clones to identify candidate peptide sequences
- Synthesis of individual candidate sequences as free synthetic peptides for validation outside the phage context
- Confirmation of binding activity using orthogonal methods such as surface plasmon resonance or ELISA-based assays
- Optimization of the lead sequence through additional rounds of synthesis and testing, sometimes including non-natural amino acid substitutions
Why Validation Outside the Phage Context Matters
A peptide’s apparent binding activity in the context of phage display, where it is displayed at high local concentration on a multivalent particle, does not always translate directly to activity as a free, monovalent synthetic peptide, making independent confirmation with synthesized material an essential step before further development.
Common Modifications Made During Optimization
Following initial validation, researchers often synthesize truncated, cyclized, or otherwise modified versions of a lead sequence to improve binding affinity, stability, or synthesis feasibility, which requires close collaboration with a peptide supplier capable of rapid, iterative custom synthesis.
Sourcing Considerations for Discovery Programs
Discovery and optimization work often benefits from a supplier offering fast turnaround on small-scale custom synthesis, since programs at this stage typically need many sequence variants tested quickly rather than large quantities of a single confirmed sequence.
Product Disclaimer & Terms of Use
IMPORTANT NOTICE: FOR RESEARCH USE ONLY (RUO)
This product is intended exclusively for laboratory research and scientific development purposes. It is NOT a drug, food, medical device, cosmetic, or diagnostic product.
